QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
Clinical trial NCT06551116 · RECRUITING
Trial details
- NCT number
- NCT06551116
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-10
- Primary completion
- 2029-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.